MedNet Solutions to Introduce New EDC/eClinical Technologies at the 2009 Drug Information Association Annual Meeting
Posted on: Thursday, 11 June 2009, 09:52 CDT
"MedNet is continuously working to expand its market-leading electronic data capture/eClinical tool set to improve study efficiencies and data quality, while reducing overall timelines and costs," stated
MedNet will be demonstrating its complete lineup of eClinical technologies in its booth (#431) in the exhibits area at the DIA Annual Meeting. All DIA attendees are invited to visit the MedNet booth to learn more about MedNet Solutions' latest technology offerings.
MedNet Solutions is a global healthcare technology company specializing in clinical study management systems designed for the global life sciences market. Applying critical insight, proven technology, and unwavering support, MedNet delivers powerful, flexible and easy-to-use web-based solutions that support our customers' clinical studies, registries and investigator initiated trials. Since 2000, MedNet has successfully supported leading pharmaceutical, medical device, and biotechnology organizations on projects spanning 6 continents and more than 40 countries. MedNet delivers a superior customer experience from beginning to end. For more information, please visit www.mednetstudy.com.
Contact Information: Dirk H. Nelson Marketing Manager 601 Carlson Parkway, Suite 605 Minnetonka, MN 55305 USA (763) 258-2735SOURCE MedNet Solutions
Source: PR Newswire
Related Articles
- MedNet Solutions Unveils New Naming and Functionality for its Flagship EDC/eClinical Offering
- MedNet Solutions Wrapping up Banner Year With Six New Studies Going Live in December
- ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications
- ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study
- ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
- FoldRx Announces Its Phase II/III Clinical Study With Lead Clinical Candidate
- Alantos Pharmaceuticals Initiates Phase 1 Clinical Studies With Lead Compound for Type II Diabetes
- CORRECTED Press Release: Vascular Solutions Announces Presentation of Final Results of 'Pocket Protector' Clinical Study of the D-Stat Flowable
- Leading Cancer Centers Commence Clinical Study for Prostate Cancer Patients Receiving External Beam Radiation Therapy
 |
 |
User Comments (0)
RSS Feeds